Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/002620 stock hub

KRX/002620 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/002620is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

134.3B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/002620

In the news

Latest news · KRX/002620

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E9.2

P25 12P50 23.1P75 39.5

ROE7.6

P25 -17.1P50 0.7P75 8.5

ROIC6.2

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/002620 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

KRW

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	37
Enterprise value	KRW 372.8B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7002620003
Last refreshed	2026-05-10
Market cap	KRW 134.3B
Price	KRW 8,600
Price currency	KRW
Rev Per Employee	17,773,351,731.62x
Sector	Healthcare
Sic	2834
Symbol	krx/002620
Website	https://www.jeilpharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.9%
EV Earnings	25.47x
EV/EBIT	9.37x
EV/EBITDA	6.81x
EV/FCF	-47.23x
EV/Sales	0.57x
FCF yield	-5.88%
P/B ratio	0.29x
P/E ratio	9.18x
P/S ratio	0.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.93%
EBITDA Margin	8.2%
Gross margin	38.55%
Gross Profit	KRW 253.5B
Gross Profit Growth	22.75%
Gross Profit Growth Q	9.33%
Gross Profit Growth3 Y	11.99%
Gross Profit Growth5 Y	5.8%
Net Income	KRW 14.6B
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth5 Y	5.07%
Pretax Margin	5.99%
Profit Margin	2.23%
Profit Per Employee	KRW 395.5M
Profitable Years	1
ROA	2.76
Roa5y	0.46
ROCE	7.04
ROE	7.64
Roe5y	-6.41
ROIC	6.18
Roic5y	1.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-10.75%
Cagr15y	5.52%
Cagr1y	9.68%
Cagr20y	7.58%
Cagr3y	-9.58%
Cagr5y	-18.86%
Div CAGR10	1.55%
Div CAGR3	11.87%
Div CAGR5	0%
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth5 Y	5.06
OCF Growth	-91.41%
OCF Growth Q	-8.67%
OCF Growth10 Y	-0.94%
Revenue Growth	-15.67x
Revenue Growth Q	-24.29x
Revenue Growth Years	0x
Revenue Growth3 Y	-6.05x
Revenue Growth5 Y	-2.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.74
Assets	KRW 876.7B
Cash	KRW 79.3B
Current Assets	KRW 373.3B
Current Liabilities	KRW 323.1B
Debt	KRW 167.4B
Debt EBITDA	KRW 3.1
Debt Equity	KRW 0.36
Debt FCF	KRW -21.2
Equity	KRW 469.1B
Interest Coverage	5.2
Liabilities	KRW 407.5B
Long Term Assets	KRW 503.4B
Long Term Liabilities	KRW 84.5B
Net Cash	KRW -88.1B
Net Cash By Market Cap	KRW -65.56
Net Debt EBITDA	KRW 1.63
Net Debt Equity	KRW 0.19
Tangible Book Value	KRW 309.5B
Tangible Book Value Per Share	KRW 20,131
WACC	5.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.16
Inventory Turnover	3.33
Net Working Capital	KRW 121.2B
Quick ratio	0.76
Working Capital	KRW 50.2B
Working Capital Turnover	KRW 16.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Growth	40%
Dividend Growth Years	1%
Dividend per share	KRW 50
Dividend Years	33
Dividend Yield	0.57%
Ex Div Date	2025-12-29
Last Dividend	KRW 70
Payout Frequency	Annual
Payout Ratio	1.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-67.93%
1Y total return	9.67%
200-day SMA	8,456.5
3Y total return	-26.08%
50-day SMA	8,713.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-64.82%
All Time High	139,000
All Time High Change	-93.81%
All Time High Date	2016-06-15
All Time Low	199.3
All Time Low Change	4,214.3%
All Time Low Date	1998-05-13
ATR	272.8
Beta	0.6
Beta1y	0.02
Beta2y	0.11
Ch YTD	6.97
High	8,740
High52	9,920
High52 Date	2025-07-24
High52ch	-13.31%
Low	8,510
Low52	7,440
Low52 Date	2025-11-05
Low52ch	15.59%
Ma50ch	-1.31%
Price vs 200-day SMA	1.7%
RSI	50.77
RSI Monthly	46.94
RSI Weekly	53.67
Sharpe ratio	0.34x
Sortino ratio	0.75
Total Return	0.52%
Tr YTD	6.97
Tr15y	123.8%
Tr1m	5.65%
Tr1w	-2.6%
Tr3m	7.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 39B
Operating Income Growth Q	65.41
Operating Income Growth5 Y	12.12
Operating margin	5.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,159,267%
Net Borrowing	11,677,310,540
Shares Insiders	76.18%
Shares Out	15,351,125
Shares Qo Q	0.15%
Shares Yo Y	0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -8.6B
Average Volume	13,916.9x
Bv Per Share	20,731.3
CAPEX	KRW -8.3B
Ch10y	-90.07
Ch15y	-32.02
Ch1m	5.65
Ch1w	-2.6
Ch1y	9
Ch20y	24.64
Ch3m	7.23
Ch3y	-27.3
Ch5y	-65.67
Ch6m	13.01
Change	-0.58%
Change From Open	-1.6
Close	8,650
Days Gap	1.04
Depreciation Amortization	14,948,845,000
Dollar Volume	48,753,400
Earnings Date	2026-05-11
EBIT	KRW 39B
EBITDA	KRW 53.9B
EPS	KRW 953
F Score	5
FCF	KRW -7.9B
FCF EV Yield	-2.12x
FCF Per Share	KRW -514
Financing CF	11,213,413,070
Fiscal Year End	December
Founded	1,959
Graham Number	21083.89489
Graham Upside	145.2
Income Tax	KRW 4.7B
Investing CF	-14,627,713,520
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2006-04-17
Last Split Type	Forward
Lynch Fair Value	KRW 4,828
Lynch Upside	-43.86
Ma150	8,346.5
Ma150ch	3.04%
Ma20	8,707
Ma20ch	-1.23%
Net CF	-3,631,416,580
Next Earnings Date	2026-05-11
Open	8,740
P OCF Ratio	344.2
Payment Date	2026-04-22
Position In Range	39.13
Ppne	243,300,476,580
Price Date	2026-05-08
Price EBITDA	KRW 2.49
Ptbv Ratio	0.43
Relative Volume	0.37x
Revenue	657,614,014,070x
SBC By Revenue	0.11x
Share Based Comp	696,530,000
Tax By Revenue	0.72x
Tax Rate	11.99%
Tr20y	331.38%
Tr6m	13.7%
Volume	5,669
Z Score	1.21

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/002620 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$50.0 annual per share

Payout ratio

+1.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2025-12-29

Performance

KRX/002620 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/002620?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+76.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

KRX/002620 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.8

Neutral momentum band

Price vs 200-day MA

+1.7%

50/200-day relationship not available

Beta (5Y)

0.60

Less volatile than the market

Sharpe ratio

0.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/002620

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/002620 stock rating?

krx/002620 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/002620 analysis?

The full report lives at /stocks/krx/002620/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/002620?

The latest report frames krx/002620 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/002620 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.